BUCHI J KEVIN 4
4 · Benitec Biopharma Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Award
Options (right to buy)
2024-12-09+35,000→ 35,000 totalExercise: $12.18Exp: 2034-12-09→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.